Health group Ascendis, which has been battling with a hefty debt pile and the threat of being forced to sell its most profitable assets, has reported that interim operating profits were up more than a third amid robust demand for vitamins and supplements during the Covid-19 pandemic.

A move to recapitalise the group is also looking more likely, with Ascendis saying two of its lenders, who want a halt to asset disposals, have now increased their share of the group’s debt vehicle to three-quarters...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.